Fact sheet: Pictet Health

Fund information
Fund name
Pictet Health I dy GBP
Fund manager company
Pictet Asset Management (Europ
Fund type
Offshore Fund
Fund managers
  • Lydia Hauetersince 31/03/2016
  • Grégoire Biollazsince 31/03/2016
  • Tazio Stornisince 27/04/2015
  • Nathalie Flurysince 27/04/2015
Fund objective
The sub-fund seeks capital growth by investing primarily in a diversified portfolio of the shares of companies operating in sectors related to health. Geographically, the investment universe is not restricted to any specific zone.
Benchmark
  • MSCI World
Investment style
Growth
Investment method
Shares
Quick stats
1 Year return
2.9%
1 Year rank in sector
-
Sector
FO Equity - Pharma Health & Biotech
Yield
-
Ongoing charge (OCF)
?A fund’s ongoing charges figure (OCF) is similar to the old-style total expense ratio. It reflects the annual charge to investors in the fund, in percentage terms, but does not include extra performance-related fees (where these are levied) or the fund’s trading expenses on its underlying investments.
1.22%
Fund size
£524m (£654m last year)
FE Risk score
?FE Risk Scores measure the riskiness of instruments relative to the FTSE 100 index of shares. Weekly volatility is measured over three years with recent behaviour counting more heavily than earlier behaviour. Cash-type investments will have scores close to zero. Funds will tend to have scores in the 0-150 range. The FTSE 100 is always scored at 100. There is no upper limit.
127
Top in this sector
Fund name1 Year
Pictet Health2.9%
Fidelity Gbl Health Care2.6%
Variopartner SICAV MVGbMdtcF1%
BB Medtech-0.1%
Wellington GlHthcr LS-1.2%
...more in FO Equity - Pharma Health & Biotech

Performance snapshot

Holdings snapshot

  • USA82.4%
    Switzerland6.7%
    Japan2.5%
    UK1.9%
    Ireland1.9%
  • Pharmaceuticals26.9%
    Biotechnology/Medical21%
    Services18.4%
    Health Care16.6%
    Others15.5%
  • US Equities82.4%
    Swiss Equities6.7%
    Japanese Equities2.5%
    UK Equities1.9%
    Irish Equities1.9%

Performance vs Sector

Cumulative performance
 1 mth3 mth6 mth1 yr3 yr5 yr
Fund-2.3%-4.3%1.9%2.9%54.3%113.4%
Sector2.1%-4.2%-3.2%-11%24%107.6%
Rank within sector------
Quartile
Calendar performance
 YTD - 20162015201420132012
Fund2.1%6.2%40.2%24.4%15.7%
Sector-10.6%7.2%28.1%41%16.7%
Rank within sector-----
Quartile
Risk statistics
Alpha
?Alpha is a measure of a fund's over- or under-performance by comparison to its benchmark. If the Alpha is 5, the fund has outperformed its benchmark by 5%; so the greater the Alpha, the greater the outperformance.
10.32
Beta
?Beta estimates a fund's volatility by comparison to that of its benchmark. A fund with a beta close to 1 means that the fund will move generally in line with the benchmark. Higher than 1 and the fund is more volatile than the benchmark and vice versa.
0.66
Sharpe
?This commonly-used measure calculates the level of return over and above the return of a notional risk-free investment, such as cash. The difference in returns is then divided by the fund's volatility. The resulting ratio is an indication of the amount of excess return generated per unit of risk.
0.91
Volatility
?Volatility (or standard deviation), when applied to an investment fund, expresses its risk. It shows how widely a range of returns varied from the fund's average return over a particular period. For example, if a fund had an average return of 5%, and its volatility was 15, this would mean that the range of its returns over the period had swung between +20% and -10%.
13.89
Tracking error
?This measures the standard deviation of a fund's excess returns over the returns of an index or benchmark portfolio. As such, it can be an indication of 'riskiness' in the manager's investment style. A Tracking Error below 2 suggests a passive approach. At 3 and above the the manager will be deploying a more active investment style.
10.79
Information ratio
?This is a useful risk-adjusted measure of actively managed fund performance. It is calculated by deducting the returns of the fund's benchmark from the fund's overall returns, then dividing the result by its tracking error. The higher the Information Ratio the better. It is generally considered that a figure of 0.5 reflects a good performance, 0.75 very good, and 1.00 outstanding.
0.67
R-Squared
?An indication of how closely correlated a fund is to an index or a benchmark. Values for R-Squared range between 0 and 1, with 0 indicating no correlation at all and 1 showing a perfect match. Values upwards of 0.7 suggest that the fund's behaviour is increasingly linked to its benchmark.
0.59
Price movement
52 week high210.88
52 week low160.52
Current bid price-
Current offer price-
Current mid price188.92
Region
1USA82.43%
2Switzerland6.66%
3Japan2.49%
4UK1.89%
5Ireland1.88%
6Money Market1.61%
7Germany1.34%
8Denmark0.87%
9Israel0.83%
Industry sector
1Pharmaceuticals26.93%
2Biotechnology/Medical20.99%
3Services18.39%
4Health Care16.62%
5Others15.46%
6Money Market1.61%
Asset type
1US Equities82.43%
2Swiss Equities6.66%
3Japanese Equities2.49%
4UK Equities1.89%
5Irish Equities1.88%
6Money Market1.61%
7German Equities1.34%
8Danish Equities0.87%
9Israeli Equities0.83%
Individual holdings
1MEDTRONIC INC4.64%
2JOHNSON & JOHNSON4.5%
3CELGENE CORP4.21%
4PFIZER INC4.2%
5UNITEDHEALTH GROUP INC4.2%
6ROCHE HLDG AG3.93%
7AMGEN INC3.9%
8THERMO FISHER SCIENTIFIC INC3.78%
9ALLERGAN INC3.6%
Management
Fund manager group
Pictet
Fund manager company
Pictet Asset Management (Europ
Fund type
Offshore Fund
Fund objective
The sub-fund seeks capital growth by investing primarily in a diversified portfolio of the shares of companies operating in sectors related to health. Geographically, the investment universe is not restricted to any specific zone.
Benchmark
  • MSCI World
Investment style
Growth
Investment method
Shares
Fund managers
NameSinceBiography
Lydia Haueter31/03/2016
Grégoire Biollaz31/03/2016
Tazio Storni27/04/2015Tazio Storni joined Pictet Asset Management in October 2014 as a Senior Investment Manager in the Sector & Theme Funds team. He began his investment career in 2005 with UBS Global Asset Management, as a financial analyst covering Biotech, Medtech and Chemical companies. In 2010 he took over the responsibility for the UBS (Lux) Equity Health Care fund. Prior to joining Pictet Asset Management Tazio worked for Bellevue Asset Management as lead portfolio manager on the BB Biotech (Lux) Fund. He holds a Masters in Biology and a PhD in Immunology from the Eidgenössische Technishe Horchschule in Zurich (ETH). Tazio is a Chartered Financial Analyst (CFA) charterholder.
Nathalie Flury27/04/2015
Compliance
Transparent for Austrian Tax, Transparent for Swiss Tax, IA Recognised, Reporting Fund Status, UCITS IV Compliant
Domicile
No data available.
Fund for sale in
Austria, Belgium, Switzerland, Chile, Cyprus, Germany, Spain, Finland, France, United Kingdom, Greece, Italy, Liechtenstein, Luxembourg, Netherlands, Norway, Offshore, Peru, Portugal, Singapore, Sweden, Taiwan - Province Of China
Pictet Health HI EUR
Initial charge5%
Annual charge0.8%
Min single investment£1,000,000
Min regular saving£0
Available in ISANo
Ongoing charge (OCF)1.27%
Total expense ratio (TER)1.26%
Bid price-
Offer price-
Mid price157.74
CurrencyEUR
Price updated01/12/2016
TypeAccumulation
Institutional or retail classInstitutional
Domicile-
Citi codeBMJ9
Pictet Health HP EUR
Initial charge5%
Annual charge1.6%
Min single investment£0
Min regular saving£0
Available in ISANo
Ongoing charge (OCF)2.07%
Total expense ratio (TER)2.05%
Bid price-
Offer price-
Mid price166.04
CurrencyEUR
Price updated01/12/2016
TypeAccumulation
Institutional or retail classRetail
Domicile-
Citi codeQ613
Pictet Health HR EUR
Initial charge5%
Annual charge2.3%
Min single investment£0
Min regular saving£0
Available in ISANo
Ongoing charge (OCF)2.77%
Total expense ratio (TER)2.76%
Bid price-
Offer price-
Mid price153.03
CurrencyEUR
Price updated01/12/2016
TypeAccumulation
Institutional or retail classRetail
Domicile-
Citi codeQ612
Pictet Health I EUR
Initial charge5%
Annual charge0.8%
Min single investment£1,000,000
Min regular saving£0
Available in ISANo
Ongoing charge (OCF)1.22%
Total expense ratio (TER)1.21%
Bid price-
Offer price-
Mid price224.69
CurrencyEUR
Price updated01/12/2016
TypeAccumulation
Institutional or retail classInstitutional
Domicile-
Citi codeQ611
Pictet Health I USD
Initial charge5%
Annual charge0.8%
Min single investment£1,000,000
Min regular saving£0
Available in ISANo
Ongoing charge (OCF)1.22%
Total expense ratio (TER)1.21%
Bid price-
Offer price-
Mid price238.42
CurrencyUSD
Price updated01/12/2016
TypeAccumulation
Institutional or retail classInstitutional
Domicile-
Citi codeP766
Pictet Health I dy GBP
Initial charge5%
Annual charge0.8%
Min single investment£1,000,000
Min regular saving£0
Available in ISANo
Ongoing charge (OCF)1.22%
Total expense ratio (TER)1.22%
Bid price-
Offer price-
Mid price188.92
CurrencyGBP
Price updated01/12/2016
TypeIncome
Institutional or retail classInstitutional
Domicile-
Citi codeGLO2
Pictet Health I dy USD
Initial charge5%
Annual charge0.8%
Min single investment£1,000,000
Min regular saving£0
Available in ISANo
Ongoing charge (OCF)1.22%
Total expense ratio (TER)1.21%
Bid price-
Offer price-
Mid price238.31
CurrencyUSD
Price updated01/12/2016
TypeIncome
Institutional or retail classInstitutional
Domicile-
Citi codeFC5H
Pictet Health P EUR
Initial charge5%
Annual charge1.6%
Min single investment£0
Min regular saving£0
Available in ISANo
Ongoing charge (OCF)2.02%
Total expense ratio (TER)2.01%
Bid price-
Offer price-
Mid price203.72
CurrencyEUR
Price updated01/12/2016
TypeAccumulation
Institutional or retail classRetail
Domicile-
Citi codeQ610
Pictet Health P USD
Initial charge5%
Annual charge1.6%
Min single investment£0
Min regular saving£0
Available in ISANo
Ongoing charge (OCF)2.02%
Total expense ratio (TER)2.01%
Bid price-
Offer price-
Mid price216.17
CurrencyUSD
Price updated01/12/2016
TypeAccumulation
Institutional or retail classRetail
Domicile-
Citi codeP767
Pictet Health P dy GBP
Initial charge5%
Annual charge1.6%
Min single investment£0
Min regular saving£0
Available in ISANo
Ongoing charge (OCF)2.02%
Total expense ratio (TER)2.01%
Bid price-
Offer price-
Mid price171.24
CurrencyGBP
Price updated01/12/2016
TypeIncome
Institutional or retail classRetail
Domicile-
Citi codeBYR3
Pictet Health P dy USD
Initial charge5%
Annual charge1.6%
Min single investment£0
Min regular saving£0
Available in ISANo
Ongoing charge (OCF)2.02%
Total expense ratio (TER)2.01%
Bid price-
Offer price-
Mid price216.12
CurrencyUSD
Price updated01/12/2016
TypeIncome
Institutional or retail classRetail
Domicile-
Citi codeA1G5
Pictet Health R EUR
Initial charge5%
Annual charge2.3%
Min single investment£0
Min regular saving£0
Available in ISANo
Ongoing charge (OCF)2.72%
Total expense ratio (TER)2.71%
Bid price-
Offer price-
Mid price187.73
CurrencyEUR
Price updated01/12/2016
TypeAccumulation
Institutional or retail classRetail
Domicile-
Citi codeQ609
Pictet Health R USD
Initial charge5%
Annual charge2.3%
Min single investment£0
Min regular saving£0
Available in ISANo
Ongoing charge (OCF)2.72%
Total expense ratio (TER)2.71%
Bid price-
Offer price-
Mid price199.2
CurrencyUSD
Price updated01/12/2016
TypeAccumulation
Institutional or retail classRetail
Domicile-
Citi codeP768
Pictet Health Z EUR
Initial charge-
Annual charge-
Min single investment£0
Min regular saving£0
Available in ISANo
Ongoing charge (OCF)0.35%
Total expense ratio (TER)-
Bid price-
Offer price-
Mid price227.74
CurrencyEUR
Price updated01/12/2016
TypeAccumulation
Institutional or retail classRetail
Domicile-
Citi codeFV6Q
Pictet Health Z USD
Initial charge-
Annual charge-
Min single investment£0
Min regular saving£0
Available in ISANo
Ongoing charge (OCF)0.35%
Total expense ratio (TER)0.35%
Bid price-
Offer price-
Mid price264.9
CurrencyUSD
Price updated01/12/2016
TypeAccumulation
Institutional or retail classRetail
Domicile-
Citi codeFOHZ
Data provided by

The Content is only for your general information and use and is not intended to address your particular requirements. The Content does not constitute any form of advice, recommendation or arrangement by Moneywise and is not intended to be relied upon by you in making (or refraining from making) any specific investment or other decisions. Appropriate independent advice should be obtained before making any such decision.

This information is sourced from our partner Financial Express. We believe the data to be correct however you should take care in using any information.

You should be aware that prices may fall as well as rise and that the income derived can go down as well as up. When buying or selling any investment that fluctuates in price or value you may get back less than you invested. Past performance is not necessarily a guide to future performance.